<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chromatin remodeling through <z:chebi fb="0" ids="15358">histone</z:chebi> modification is an important mechanism of epigenetic gene dysregulation in human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, little is known about global alteration of <z:chebi fb="0" ids="15358">histone</z:chebi> status during <z:mp ids='MP_0002006'>tumorigenesis</z:mp> and <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="15358">Histone</z:chebi> H3 status was examined in benign and <z:e sem="disease" ids="C0346629" disease_type="Neoplastic Process" abbrv="">malignant colorectal tumors</z:e> by immunohistochemistry and Western blotting </plain></SENT>
<SENT sid="3" pm="."><plain>For immunohistochemical evaluation, 4 anti-<z:chebi fb="0" ids="15358">histone</z:chebi> H3 antibodies, specific to dimethylation at lysine 4 (H3K4me2), acetylation at lysine 9 (H3K9ac), dimethylation at lysine 9 (H3K9me2), and trimethylation at lysine 27 (H3K27me3), were used </plain></SENT>
<SENT sid="4" pm="."><plain>On immunohistochemistry, H3K4me2, H3K9ac, and H3K27me3 showed no significant changes between <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>On the other hand, the global level of H3K9me2 was distinctly higher in neoplastic cells (<z:mpath ids='MPATH_270'>adenoma</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>) than in <z:mpath ids='MPATH_458'>normal</z:mpath> glandular cells </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, it was significantly higher in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> than in <z:mpath ids='MPATH_270'>adenoma</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>Correspondingly, Western blotting confirmed that H3K9me2 expression was significantly higher in <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> than in <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal mucosa </plain></SENT>
<SENT sid="8" pm="."><plain>No alteration of H3K9me2 was observed with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> differentiation and with the histological subtypes of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggest that aberration of the global H3K9me2 level is an important epigenetic event in colorectal <z:mp ids='MP_0002006'>tumorigenesis</z:mp> and <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> involved with gene regulation in neoplastic cells through chromatin remodeling </plain></SENT>
</text></document>